These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 4977282)

  • 1. Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.
    Gotschlich EC; Liu TY; Artenstein MS
    J Exp Med; 1969 Jun; 129(6):1349-65. PubMed ID: 4977282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide.
    Vann WF; Liu TY; Robbins JB
    Infect Immun; 1976 Jun; 13(6):1654-62. PubMed ID: 184043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic response of man to group B meningococcal polysaccharide vaccines.
    Wyle FA; Artenstein MS; Brandt BL; Tramont EC; Kasper DL; Altieri PL; Berman SL; Lowenthal JP
    J Infect Dis; 1972 Nov; 126(5):514-21. PubMed ID: 4197754
    [No Abstract]   [Full Text] [Related]  

  • 4. Modification of meningococcal polysaccharide antigens for use in passive hemagglutination tests.
    Hammond BW; Kingsbury DT; Weiss E
    J Immunol; 1968 Oct; 101(4):808-9. PubMed ID: 4971477
    [No Abstract]   [Full Text] [Related]  

  • 5. Production and degradation of serogroup B Neisseria meningitidis polysaccharide.
    Maloney PC; Schneider H; Brandt BL
    Infect Immun; 1972 Nov; 6(5):657-8. PubMed ID: 4629201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a subgroup antigen on the Neisseria meningitidis group C capsular polysaccharide.
    Apicella MA
    J Infect Dis; 1974 Feb; 129(2):147-53. PubMed ID: 4129826
    [No Abstract]   [Full Text] [Related]  

  • 7. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.
    Gotschlich EC; Goldschneider I; Artenstein MS
    J Exp Med; 1969 Jun; 129(6):1367-84. PubMed ID: 4977283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical properties of Neisseria meningitidis group X polysaccharide antigen.
    Apicella MA; Robinson JA
    Infect Immun; 1972 Nov; 6(5):773-8. PubMed ID: 4629206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elaboration of both the group W135 and group Y capsular polysccharides by a single strain of Neisseria meningitidis.
    Brandt BL; Pier GB; Goroff DK; Altieri PL; Griffiss JM
    J Gen Microbiol; 1980 May; 118(1):39-43. PubMed ID: 6775049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolation and characteristics of polysaccharide antigens from meningococci of groups A and C].
    Kuvakina VI; Smirnova-Mutusheva MA; Kholchev NV; Margulis IL; Bulanova EB
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Apr; 51(4):63-9. PubMed ID: 4208498
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemagglutination inhibition for serogrouping of Neisseria meningitidis.
    Cohen RL; Artenstein MS
    Appl Microbiol; 1972 Feb; 23(2):289-92. PubMed ID: 4622825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.
    Gotschlich EC; Goldschneider I; Artenstein MS
    J Exp Med; 1969 Jun; 129(6):1385-95. PubMed ID: 4977284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effectiveness of group-A and -C meningococcal polysaccharide vaccines by molecular parameters].
    Bobyleva GV; Kuvakina VI; Valerius II
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):758-63. PubMed ID: 3122649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface polysaccharide of Moraxella non-liquefaciens identical to Neisseria meningitidis group B capsular polysaccharide. A chemical and immunological investigation.
    Bøvre K; Bryn K; Closs O; Hagen N; Frøholm LO
    NIPH Ann; 1983 Jun; 6(1):65-73. PubMed ID: 6413906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide.
    Liu TY; Gotschlich EC; Dunne FT; Jonssen EK
    J Biol Chem; 1971 Aug; 246(15):4703-12. PubMed ID: 4327325
    [No Abstract]   [Full Text] [Related]  

  • 16. Standardization and control of meningococcal vaccines, group A and group C polysaccharides.
    Wong KH; Barrera O; Sutton A; May J; Hochstein DH; Robbins JD; Robbins JB; Parkman PD; Seligmann EB
    J Biol Stand; 1977; 5(3):197-215. PubMed ID: 408354
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection.
    Ricci S; Bardotti A; D'Ascenzi S; Ravenscroft N
    Vaccine; 2001 Feb; 19(15-16):1989-97. PubMed ID: 11228369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis.
    Kasper DL; Winkelhake JL; Zollinger WD; Brandt BL; Artenstein MS
    J Immunol; 1973 Jan; 110(1):262-8. PubMed ID: 4346607
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a native cell wall complex from Neisseria meningitidis.
    Zollinger WD; Kasper DL; Veltri BJ; Artenstein MS
    Infect Immun; 1972 Nov; 6(5):835-51. PubMed ID: 4629210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.